Catheter-directed thrombolysis for deep vein thrombosis: 2021 update

1. Huang, W, Goldberg, RJ, Anderson, FA, et al. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE Study (1985–2009). Am J Med 2014; 127: 829–839:e5.
Google Scholar | Crossref | Medline | ISI2. Ortel, T, Neumann, I, Ageno, W, et al. American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of deep vein thrombosis and pulmonary embolism. Blood Advances 2020; 4: 4693–4738.
Google Scholar | Crossref | Medline3. Kahn, SR, Shrier, I, Julian, JA, et al. Determinants and time course of the post-thrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149: 698–707.
Google Scholar | Crossref | Medline | ISI4. Semba, CP, Dake, MD. Iliofemoral deep venous thrombosis: Aggressive therapy with catheter-directed thrombolysis. Radiology 1994; 191: 487–494.
Google Scholar | Crossref | Medline | ISI5. Enden, T, Haig, Y, Klow, NE, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): A randomised controlled trial. Lancet 2012; 379: 31–38.
Google Scholar | Crossref | Medline | ISI**6. Vedantham, S, Goldhaber, SZ, Julian, J, et al.; ATTRACT Trial Investigators . Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2017; 377: 2240–2252.
Google Scholar | Crossref | Medline7. Kahn, SR, Shbaklo, H, Lamping, DL, et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 2008; 6: 1105–1112.
Google Scholar | Crossref | Medline | ISI8. Milling, TJ, Pollack, CV. A review of guidelines on anticoagulation reversal across different clinical scenarios: Is there a general consensus? Am J Emerg Med 2020; 38: 1890–1903.
Google Scholar | Crossref | Medline9. Li, R, Yuan, M, Cheng, J, et al. Risk of post-thrombotic syndrome after deep vein thrombosis treated with rivaroxaban versus vitamin-K antagonists: A systematic review and meta-analysis. Thromb Res 2020; 196: 340–348.
Google Scholar | Crossref | Medline10. Razavi, MK, Salter, A, Goldhaber, SZ, et al. Correlation between post-procedure residual thrombus and clinical outcome in deep vein thrombosis patients receiving pharmacomechanical thrombolysis in a multi-center randomized trial. J Vasc Interv Radiol 2020; 31: 1517–1528.
Google Scholar | Crossref | Medline11. Gagne, PJ, Tahara, RW, Fastabend, CP, et al. Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction. J Vasc Surg Venous Lymphat Disord 2017; 5: 678–687.
Google Scholar | Crossref | Medline12. Razavi, MK, Jaff, MR, Miller, LE. Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction: Systematic review and meta-analysis. Circ Cardiovasc Interv 2015; 8: e002772.
Google Scholar | Crossref | Medline | ISI13. Mewissen, MW, Seabrook, GR, Meissner, MH, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: Report of a national multicenter registry. Radiology 1999; 211: 39–49.
Google Scholar | Crossref | Medline | ISI14. Vedantham, S, Vesely, TM, Sicard, GA, et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2004; 15: 565–574.
Google Scholar | Crossref | Medline | ISI**15. Haig, Y, Enden, T, Grøtta, O, et al.; CaVenT Study Group . Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol 2016; 3: e64–71.
Google Scholar | Crossref | Medline | ISI16. Enden, T, Wik, HS, Kvam, AK, et al. Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: Secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study. BMJ Open 2013; 3: e002984.
Google Scholar | Crossref | Medline | ISI17. Notten, P, ten Cate-Hoek, AJ, Arnoldussen, CWKP, et al. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. Lancet Haematol 2020; 7: e40–e49.
Google Scholar | Crossref | Medline**18. Comerota, AJ, Kearon, C, Gu, C, et al.; ATTRACT Trial Investigators . Endovascular thrombus removal for acute iliofemoral deep vein thrombosis: Analysis from a stratified multicenter randomized trial. Circulation 2019; 139: 1162–1173.
Google Scholar | Crossref | Medline19. Kearon, C, Gu, C, Julian, JA, et al.; ATTRACT Trial Investigators . Pharmacomechanical catheter-directed thrombolysis for acute femoral-popliteal deep-vein thrombosis: Analysis from a stratified randomized trial. Thromb Haemost 2019; 119: 633–634.
Google Scholar | Crossref | Medline20. Kahn, SR, Julian, JA, Kearon, C, et al.; ATTRACT Trial Investigators . Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep vein thrombosis. J Vasc Surg Venous Lymphat Disord 2020; 8: 8–23.
Google Scholar | Crossref | Medline21. Li, W, Kessinger, C, Orli, M, et al. Time-restricted salutary effects of blood flow restoration on venous thrombosis and vein wall injury in mouse and human subjects. Circulation 2021; 143: 1224–1238.
Google Scholar | Crossref | Medline22. Haig, Y, Enden, T, Slagsvold, CE, et al. Residual rates of reflux and obstruction and their correlation to post-thrombotic syndrome in a randomized study on catheter-directed thrombolysis for deep vein thrombosis. J Vasc Surg Venous Lymphat Disord 2014; 2: 123–130.
Google Scholar | Crossref | Medline | ISI*23. Weinberg, I, Vedantham, S, Salter, A, et al.; ATTRACT Trial Investigators . Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT multicenter randomized trial. Vasc Med 2019; 24: 442–451.
Google Scholar | SAGE Journals | ISI24. Moriarty, JM, Rueda, V, Liao, M, et al. Endovascular removal of thrombus and right heart masses using the AngioVac system: Results of 234 patients from the prospective, multicenter registry of AngioVac Procedures in Detail (RAPID). J Vasc Interv Radiol 2021; 32: 549–557.
Google Scholar | Crossref | Medline25. Engelberger, RP, Spirk, D, Willenberg, T, et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Circ Cardiovasc Interv 2015; 8: e002027.
Google Scholar | Crossref | Medline | ISI26. Engerberger, RP, Stuck, A, Spirk, D, et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: 1-year follow-up data of a randomized-controlled trial. J Thromb Haemost 2017; 15: 1351–1360.
Google Scholar | Crossref | Medline27. Enden, T, Resch, S, White, C, et al. Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis. J Thromb Haemost 2013; 11: 1032–1042.
Google Scholar | Crossref | Medline | ISI28. Magnuson, EA, Chinnakondepalli, K, Vilain, K, et al. Cost-effectiveness of pharmacomechanical catheter-directed thrombolysis vs. standard anticoagulation in patients with proximal deep-vein thrombosis: Results from the ATTRACT Trial. Circ Cardiovasc Qual Outcomes 2019; 12: e005659.
Google Scholar | Crossref | Medline29. Anderson, JL, Heidenreich, PA, Barnett, PG, et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: A report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. Circulation 2014; 129: 2329–2345.
Google Scholar | Crossref | Medline | ISI30. Vedantham, S, Sista, AK, Klein, SJ, et al.; Society of Interventional Radiology and Cardiovascular and Interventional Radiological Society of Europe Standards of Practice Committees . Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol 2014; 25: 1317–1325.
Google Scholar | Crossref | Medline | ISI31. Vedantham, S, Piazza, G, Sista, AK, et al. Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism. J Thromb Thrombolysis 2016; 41: 68–80.
Google Scholar | Crossref | Medline*32. Bashir, R, Zack, CJ, Zhao, H, et al. Comparative outcomes of catheter-directed thrombolysis plus anticoagulation vs anticoagulation alone to treat lower-extremity proximal deep vein thrombosis. JAMA Intern Med 2014; 174: 1494–1501.
Google Scholar | Crossref | Medline | ISI33. Kaufman, JA, Barnes, GD, Chaer, RA, et al. Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease: Developed in collaboration with the American College of Cardiology, American College of Chest Physicians, American College of Surgeons Committee on Trauma, American Heart Association, Society for Vascular Surgery, and Society for Vascular Medicine. J Vasc Interv Radiol 2020; 31: 1529–1544.
Google Scholar | Crossref | Medline34. National Institute for Health and Care Excellence . Percutaneous mechanical thrombectomy for acute deep vein thrombosis of the leg. Interventional procedures guidance. NICE Guidance, www.nice.org.uk/guidance/ipg651 (2019, accessed September 14, 2021).
Google Scholar35. Kakkos, SK, Gohel, M, Baekgaard, N, et al. European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg 2021; 61: 9–82.
Google Scholar | Crossref | Medline36. Kollias, A, Kyriakoulis, KG, Lagou, S, et al. Venous thromboembolism in COVID-19: A systematic review and meta-analysis. Vasc Med 2021; 26: 415–425.
Google Scholar | SAGE Journals

留言 (0)

沒有登入
gif